Incyte Biosciences CANADA

Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. World-class science and R&D drive Incyte’s business and its commitment to making a difference in the lives of patients through scientific discovery.

We have an experienced team with a track record of success, and our goal is to create first-in-class and best-in-class therapeutics to meet serious unmet medical needs. We are advancing a growing portfolio of medicines across Oncology and Inflammation & Autoimmunity.

Headquartered in Wilmington, Delaware, United States, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit and follow@Incyte.


Incyte Biosciences Canada Corporation
6500 Trans-Canada Highway, Suite 400
Pointe-Claire, Quebec
Canada H9R 0A5

For general inquiries and to contact Incyte Canada, please contact

To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Biosciences Canada Medical Information: or 1-833-309-2759

For further information on Incyte’s products marketed in Canada, please download Product Monograph.

Minjuvi tafasitamab for injection 200/mg/vial

Pemazyre (pemigatinib) tablets logo